Importance of P450 reductase activity in determining sensitivity of breast tumour cells to the bioreductive drug, tirapazamine (SR 4233).

P450 reductase (NADPH:cytochrome P450 reductase, EC 1.6.2.4) is known to be important in the reductive activation of the benzotriazene-di-N-oxide tirapazamine (SR 4233). Using a panel of six human breast adenocarcinoma cell lines we have examined the relationship between P450 reductase activity and...

Descripción completa

Detalles Bibliográficos
Autores principales: Patterson, A. V., Barham, H. M., Chinje, E. C., Adams, G. E., Harris, A. L., Stratford, I. J.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1995
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033939/
https://www.ncbi.nlm.nih.gov/pubmed/7577460

Ejemplares similares

Ejemplares similares